An elevated level of Sema3A in the central nervous system (CNS) including the hippocampus and cerebellum has been observed in various neurologic and psychiatric diseases (Eastwood et al., 2003; Good et al., 2004; Van Battum et al., 2015), but its role in depression is not fully understood. Here, SEMA3A is linked to depressive symptom measurement.